Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre hospitalier de l'Université de Montréal (CHUM)
Abramson Cancer Center at Penn Medicine
Pusan National University Hospital
University of California, Davis
M.D. Anderson Cancer Center
University Hospital Heidelberg
University Health Network, Toronto
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Carevive Systems, Inc.
University of Pennsylvania
City of Hope Medical Center
Duke University
VA Office of Research and Development
Ohio State University Comprehensive Cancer Center
Royal North Shore Hospital
Ohio State University Comprehensive Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
Wake Forest University Health Sciences
Abramson Cancer Center at Penn Medicine
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
University of California, Irvine
Wake Forest University Health Sciences
Boehringer Ingelheim
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Fred Hutchinson Cancer Center
Kaiser Permanente
Intuitive Surgical
University of Colorado, Denver
Istanbul University
Varian, a Siemens Healthineers Company
Complement Theory Inc.
Guangzhou University of Traditional Chinese Medicine
City of Hope Medical Center
Lithuanian University of Health Sciences
Institut Curie
UNICANCER
University of Utah
Hasan Kalyoncu University
Massachusetts General Hospital
City of Hope Medical Center
M.D. Anderson Cancer Center
Hannover Medical School
Tufts University
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
St. Joseph's Healthcare Hamilton